HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W Kreuz Selected Research

von Willebrand factor drug combination factor VIII

1/2016First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
5/2014A review of immune tolerance induction with Haemate P in haemophilia A.
11/2008Haemate P/Humate-P for the treatment of von Willebrand disease: considerations for use and clinical experience.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W Kreuz Research Topics

Disease

12Hemophilia A (Haemophilia)
01/2016 - 01/2001
6Hemorrhage
01/2014 - 02/2001
5Thrombosis (Thrombus)
11/2008 - 11/2000
2von Willebrand Diseases (von Willebrand's Disease)
11/2008 - 11/2008
1Joint Diseases (Joint Disease)
05/2015
1Thrombasthenia (Glanzmann Thrombasthenia)
01/2014
1Angioedema
08/2013
1Edema (Dropsy)
08/2013
1Fever (Fevers)
09/2010
1Infections
09/2010
1Disease Progression
05/2009
1Factor VII Deficiency (Hypoproconvertinemia)
01/2009
1Anaphylaxis (Anaphylactic Shock)
01/2008
1Hemophilia B (Haemophilia B)
01/2008
1Hereditary Angioedemas
01/2008
1Afibrinogenemia (Fibrinogen Deficiency)
04/2007
1Hematoma
04/2007
1Body Weight (Weight, Body)
09/2006
1Venous Thrombosis (Deep-Vein Thrombosis)
11/2000
1Budd-Chiari Syndrome (Budd Chiari Syndrome)
11/2000
1Purpura
02/2000

Drug/Important Bio-Agent (IBA)

9Factor VIII (Coagulation Factor VIII)IBA
01/2016 - 01/2001
3von Willebrand factor drug combination factor VIIIIBA
01/2016 - 11/2008
3Protein CIBA
02/2003 - 11/2000
2anti-inhibitor coagulant complexIBA
05/2015 - 01/2010
2recombinant FVIIa (rFVIIa)FDA Link
01/2014 - 01/2008
2Tissue Plasminogen Activator (Alteplase)FDA Link
03/2001 - 02/2000
2AntibodiesIBA
01/2001 - 11/2000
1IsoantibodiesIBA
01/2014
1AndrogensIBA
08/2013
1A-factor (Streptomyces)IBA
09/2011
1von Willebrand FactorIBA
09/2011
1Anti-Bacterial Agents (Antibiotics)IBA
09/2010
1Blood Coagulation Factors (Coagulation Factor)IBA
05/2009
1Rituximab (Mabthera)FDA Link
05/2009
1Factor VII (Proconvertin)IBA
01/2009
1human F8 proteinFDA Link
11/2008
1Factor IX (Coagulation Factor IX)FDA LinkGeneric
01/2008
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2008
1Factor VIIa (Activated Factor VII)IBA
01/2008
1Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
01/2008
1Fibrinogen (Factor I)FDA Link
04/2007
1recombinant factor VIII SQIBA
03/2007
1efavirenz (Sustiva)FDA Link
09/2006
1Dihydrotachysterol (AT 10)IBA
09/2006
1Chromogenic CompoundsIBA
09/2006
1A 7 (A-7)IBA
02/2003
1factor V LeidenIBA
02/2001
1ORALIT (ORS)IBA
11/2000
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
11/2000
1HomocysteineIBA
11/2000
1Cardiolipins (Cardiolipin)IBA
11/2000
1Prothrombin (Factor II)IBA
11/2000
1ThrombinFDA Link
11/2000
1Factor V (Coagulation Factor V)IBA
11/2000
1Lipoprotein(a)IBA
11/2000
1Protein SIBA
11/2000

Therapy/Procedure

4Therapeutics
11/2008 - 09/2004
1Operative Surgical Procedures
08/2013
1Catheters
02/2003
1Prostheses and Implants (Prosthesis)
03/2001
1Thrombolytic Therapy
03/2001